1.Sepsis, cardiovascular events and short-term mortality risk in critically ill patients.
Sharlene HO ; Hwee Pin PHUA ; Wei Yen LIM ; Niranjana MAHALINGAM ; Guan Hao Chester TAN ; Ser Hon PUAH ; Jin Wen Sennen LEW
Annals of the Academy of Medicine, Singapore 2022;51(5):272-282
INTRODUCTION:
There is paucity of data on the occurrence of cardiovascular events (CVEs) in critically ill patients with sepsis. We aimed to describe the incidence, risk factors and impact on mortality of CVEs in these patients.
METHODS:
This was a retrospective cohort study of critically ill patients admitted to the medical intensive care unit (ICU) between July 2015 and October 2016. The primary outcome was intra-hospital CVEs, while the secondary outcomes were in-hospital mortality, ICU and hospital length of stay.
RESULTS:
Patients with sepsis (n=662) had significantly more CVEs compared to those without (52.9% versus 23.0%, P<0.001). Among sepsis patients, 350 (52.9%) had 1 or more CVEs: 59 (8.9%) acute coronary syndrome; 198 (29.9%) type 2 myocardial infarction; 124 (18.7%) incident atrial fibrillation; 76 (11.5%) new or worsening heart failure; 32 (4.8%) cerebrovascular accident; and 33 (5.0%) cardiovascular death. Factors associated with an increased risk of CVEs (adjusted relative risk [95% confidence interval]) included age (1.013 [1.007-1.019]); ethnicity-Malay (1.214 [1.005-1.465]) and Indian (1.240 [1.030-1.494]) when compared to Chinese; and comorbidity of ischaemic heart disease (1.317 [1.137-1.527]). There were 278 patients (79.4%) who developed CVEs within the first week of hospitalisation. Sepsis patients with CVEs had a longer median (interquartile range [IQR]) length of stay in the ICU (6 [3-12] vs 4 [2-9] days, P<0.001), and hospital (21 [10-42] vs 15 [7-30] days, P<0.001) compared to sepsis patients without CVEs. There was no difference in in-hospital mortality between the 2 groups (46.9% vs 45.8%, P=0.792).
CONCLUSION
CVEs complicate half of the critically ill patients with sepsis, with 79.4% of patients developing CVEs within the first week of hospitalisation, resulting in longer ICU and hospital length of stay.
Cardiovascular Diseases/epidemiology*
;
Critical Illness/epidemiology*
;
Hospital Mortality
;
Humans
;
Intensive Care Units
;
Length of Stay
;
Retrospective Studies
;
Risk Factors
;
Sepsis/epidemiology*
3.Association of vitamin D deficiency with clinical outcomes in critically ill Korean children
Won Kyoung JHANG ; Da Hyun KIM ; Seong Jong PARK
Nutrition Research and Practice 2020;14(1):12-19
mortality.CONCLUSION: There is a high prevalence of VDD in critically ill Korean children. There were significant associations between the 25(OH) vitamin D level and gastrointestinal/hepatobiliary disorders, the pMODS score and with coagulation related factors. Further large-scale studies with more specific subgroup analyses are required to more precisely assess the clinical implications of VDD in critically ill pediatric patients.]]>
Bilirubin
;
Blood Platelets
;
C-Reactive Protein
;
Child
;
Critical Illness
;
Disseminated Intravascular Coagulation
;
Hemostasis
;
Humans
;
Intensive Care Units
;
Length of Stay
;
Mortality
;
Multiple Organ Failure
;
Pediatrics
;
Prevalence
;
Prothrombin Time
;
Serum Albumin
;
Thrombosis
;
Ventilators, Mechanical
;
Vitamin D Deficiency
;
Vitamin D
;
Vitamins
4.Analysis of the characteristics of unplanned admission to the intensive care unit after general surgery
Jaesuk KIM ; Yeong Deok KIM ; Dong Reul LEE ; Kye Min KIM ; Woo Yong LEE ; Sangseok LEE
Anesthesia and Pain Medicine 2019;14(2):230-235
BACKGROUND: Unplanned intensive care unit admission (UIA) is associated with perioperative morbidity and mortality, and can be used as a surrogate marker for patient safety. This study aimed to compare the characteristics of planned and unplanned intensive care unit (ICU) admission groups. METHODS: We retrospectively reviewed the electronic medical records of adult patients admitted to the ICU after abdominal and thyroid surgery under general anesthesia between 2016 and 2017. Preoperative, intraoperative, and postoperative information of enrolled patients was recorded. We compared patients' characteristics and outcomes between the unplanned and planned admission groups. RESULTS: In the total cohort, the proportion of UIA was 82.8% (202/244). In the unplanned admission group, total hospital stay was significantly shorter and ICU stay longer than that in the planned admission group (19.0 and 3.0 days, respectively vs. 28.5 and 2.0 days, respectively). In-hospital mortality rates were 21.3% and 7.1% in the unplanned and planned groups, respectively (P = 0.055). Patients in the UIA group showed higher Acute Physiology And Chronic Health Evaluation II scores, higher American Society of Anesthesiologist physical status class, and more co-morbidities than those in the planned group. There were significant differences in the incidence of UIA among surgery types. CONCLUSIONS: The UIA group had a relatively high mortality rate and longer ICU stay. More critically ill patients tended to be admitted to the ICU without planning.
Adult
;
Anesthesia
;
Anesthesia, General
;
APACHE
;
Biomarkers
;
Cohort Studies
;
Critical Care
;
Critical Illness
;
Electronic Health Records
;
Hospital Mortality
;
Humans
;
Incidence
;
Intensive Care Units
;
Length of Stay
;
Mortality
;
Patient Safety
;
Perioperative Care
;
Retrospective Studies
;
Thyroid Gland
5.Validation of Voriconazole Therapeutic Drug Monitoring in Lung Transplant Recipients Receiving Voriconazole alone for Treatment of Invasive Aspergillosis
Yu Jeong SON ; Kyung A LEE ; Ju Hee JO ; Jae Song KIM ; Eun Sun SON ; Moo Suk PARK
Korean Journal of Clinical Pharmacy 2019;29(2):89-100
BACKGROUND: Invasive aspergillosis (IA) is associated with high morbidity and mortality, particularly among immunocompromised patients, such as lung transplant recipients. Voriconazole, the first-line therapy for IA, shows a non-linear pharmacokinetic profile and has a narrow therapeutic range. Careful and appropriate administration is necessary, primarily because it is used for critically ill patients; however, the clinical usefulness of therapeutic drug monitoring (TDM) has not been sufficiently verified. Therefore, in this study, we validated the safety and efficacy of voriconazole TDM in lung transplant recipients receiving only voriconazole for IA treatment. METHODS: The electronic medical records of lung transplant recipients (≥19 years of age) administered only voriconazole for > 7 days for treatment of IA from June 1, 2013 to May 31, 2018 were analyzed retrospectively. RESULTS: Among the 54 patients, 27 each were allocated to TDM and non-TDM groups, respectively. There were no significant differences in patient characteristics between the two groups except for ICU-hospitalization status. Of the TDM group patients, 81.5% needed adjustment of voriconazole dosage because the levels were out of target range. Comparison of two groups showed that treatment response was higher throughout treatment and switching rates of second-line agents were significantly lower in the TDM group, but it was insufficient to confirm safety improvements through voriconazole TDM. CONCLUSION: Considering that the treatment response tended to be higher and the rates of switching to second-line antifungal agents were lower in the TDM group, voriconazole TDM may increase the therapeutic effect on IA in lung transplant patients.
Antifungal Agents
;
Aspergillosis
;
Critical Illness
;
Drug Monitoring
;
Electronic Health Records
;
Humans
;
Immunocompromised Host
;
Lung Transplantation
;
Lung
;
Mortality
;
Retrospective Studies
;
Transplant Recipients
;
Voriconazole
6.The effect of high fat dietary modification and nutritional status on the outcome of critically ill ventilated children: single-center study
Nehal Mohamed EL KOOFY ; Hanaa Ibrahim RADY ; Shrouk Moataz ABDALLAH ; Hafez Mahmoud BAZARAA ; Walaa Ahmed RABIE ; Ahmed Ali EL-AYADI
Korean Journal of Pediatrics 2019;62(9):344-352
BACKGROUND: Ventilator dependency constitutes a major problem in the intensive care setting. Malnutrition is considered a major determinant of extubation failure, however, attention has been attracted to modulating carbon dioxide production through decreasing carbohydrate loading and increasing the percent of fat in enteral feeds. The detected interrelation between substrate oxidation and ventilation outcome became the base of several research to determine the appropriate composition of the nonprotein calories of diet in ventilated patients. PURPOSE: We aimed to assess the effect of high-fat dietary modification and nutritional status on ventilatory and final outcomes of pediatric intensive care. METHODS: Fifty-one ventilated children (1 month to 12 years of age) with pulmonary disease who could be enterally fed, in the Cairo University Pediatric intensive care unit, were divided into 2 groups: group A included 25 patients who received isocaloric high-fat, low-carbohydrate diet; group B included 26 patients who received standard isocaloric diet. Comprehensive nutritional assessment was done for all patients. RESULTS: Group A had a significant reduction in carbon dioxide tension, but no similar reduction in the duration or level of ventilatory support. Assisted minute ventilation was predicted by weight-for-age and caloric intake rather than the type of diet. Poor nutritional status was associated with higher mortality and lower extubation rates. Mild hypertriglyceridemia and some gastrointestinal intolerance were significant in group A, with no impact on the adequacy of energy or protein delivery. CONCLUSION: The high-fat enteral feeding protocol may contribute to reducing carbon dioxide tension, with mild hypertriglyceridemia and negligible gastrointestinal intolerance as potential adverse effects. Optimization of nutritional status rather than dietary modification may improve ventilatory and survival outcomes in critically ill-ventilated children.
Carbon Dioxide
;
Child
;
Critical Care
;
Critical Illness
;
Diet
;
Diet, High-Fat
;
Energy Intake
;
Enteral Nutrition
;
Food Habits
;
Humans
;
Hypertriglyceridemia
;
Intensive Care Units
;
Lung Diseases
;
Malnutrition
;
Mortality
;
Nutrition Assessment
;
Nutritional Status
;
Ventilation
;
Ventilators, Mechanical
7.Procalcitonin-Guided Treatment on Duration of Antibiotic Therapy and Cost in Septic Patients (PRODA): a Multi-Center Randomized Controlled Trial
Kyeongman JEON ; Jae Kyung SUH ; Eun Jin JANG ; Songhee CHO ; Ho Geol RYU ; Sungwon NA ; Sang Bum HONG ; Hyun Joo LEE ; Jae Yeol KIM ; Sang Min LEE
Journal of Korean Medical Science 2019;34(14):e110-
BACKGROUND: The objective of this study was to establish the efficacy and safety of procalcitonin (PCT)-guided antibiotic discontinuation in critically ill patients with sepsis in a country with a high prevalence of antimicrobial resistance and a national health insurance system. METHODS: In a multi-center randomized controlled trial, patients were randomly assigned to a PCT group (stopping antibiotics based on a predefined cut-off range of PCT) or a control group. The primary end-point was antibiotic duration. We also performed a cost-minimization analysis of PCT-guided antibiotic discontinuation. RESULTS: The two groups (23 in the PCT group and 29 in the control group) had similar demographic and clinical characteristics except for need for renal replacement therapy on ICU admission (46% vs. 14%; P = 0.010). In the per-protocol analysis, the median duration of antibiotic treatment for sepsis was 4 days shorter in the PCT group than the control group (8 days; interquartile range [IQR], 6–10 days vs. 14 days; IQR, 12–21 days; P = 0.001). However, main secondary outcomes, such as clinical cure, 28-day mortality, hospital mortality, and ICU and hospital stays were not different between the two groups. In cost evaluation, PCT-guided therapy decreased antibiotic costs by USD 30 (USD 241 in the PCT group vs. USD 270 in the control group). The results of the intention-to-treat analysis were similar to those obtained for the per-protocol analysis. CONCLUSION: PCT-guided antibiotic discontinuation in critically ill patients with sepsis could reduce the duration of antibiotic use and its costs with no apparent adverse outcomes. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02202941
Anti-Bacterial Agents
;
Biomarkers
;
Calcitonin
;
Costs and Cost Analysis
;
Critical Illness
;
Hospital Mortality
;
Humans
;
Intensive Care Units
;
Length of Stay
;
Mortality
;
National Health Programs
;
Prevalence
;
Renal Replacement Therapy
;
Sepsis
8.Effect of Institutional Case Volume on In-Hospital and Long-Term Mortality in Critically Ill Patients Requiring Mechanical Ventilation for 48 Hours or More
Hannah LEE ; Seongmi CHOI ; Eun Jin JANG ; Juhee LEE ; Dalho KIM ; Seokha YOO ; Seung Young OH ; Ho Geol RYU
Journal of Korean Medical Science 2019;34(34):e212-
BACKGROUND: The purpose of this study was to evaluate whether institutional case volume affects clinical outcomes in patients receiving mechanical ventilation for 48 hours or more. METHODS: We conducted a nationwide retrospective cohort study using the database of Korean National Healthcare Insurance Service. Between January 2007 and December 2016, 158,712 adult patients were included at 55 centers in Korea. Centers were categorized according to the average annual number of patients: > 500, 500 to 300, and < 300. RESULTS: In-hospital mortality rates in the high-, medium-, and low-volume centers were 32.6%, 35.1%, and 39.2%, respectively. After adjustment, in-hospital mortality was significantly higher in low-volume centers (adjusted odds ratio [OR], 1.332; 95% confidence interval [CI], 1.296–1.368; P < 0.001) and medium-volume centers (adjusted OR, 1.125; 95% CI, 1.098–1.153; P < 0.001) compared to high-volume centers. Long-term survival for up to 8 years was better in high-volume centers. CONCLUSION: Centers with higher case volume (> 500 patients/year) showed lower in-hospital mortality and long-term mortality, compared to centers with lower case volume (< 300 patients/year) in patients who required mechanical ventilation for 48 hours or more.
Adult
;
Cohort Studies
;
Critical Illness
;
Delivery of Health Care
;
Hospital Mortality
;
Humans
;
Insurance
;
Korea
;
Mortality
;
Odds Ratio
;
Respiration, Artificial
;
Retrospective Studies
9.Prognostic Value of Admission Blood Glucose Level in Critically Ill Patients Admitted to Cardiac Intensive Care Unit according to the Presence or Absence of Diabetes Mellitus
Sua KIM ; Soo Jin NA ; Taek Kyu PARK ; Joo Myung LEE ; Young Bin SONG ; Jin Oh CHOI ; Joo Yong HAHN ; Jin Ho CHOI ; Seung Hyuk CHOI ; Hyeon Cheol GWON ; Chi Ryang CHUNG ; Kyeongman JEON ; Gee Young SUH ; Jeong Hoon YANG
Journal of Korean Medical Science 2019;34(9):e70-
BACKGROUND: Admission blood glucose (BG) level is a predictor of mortality in critically ill patients with various conditions. However, limited data are available regarding this relationship in critically ill patients with cardiovascular diseases according to diabetic status. METHODS: A total of 1,780 patients (595 with diabetes) who were admitted to cardiac intensive care unit (CICU) were enrolled from a single center registry. Admission BG level was defined as maximal serum glucose level within 24 hours of admission. Patients were divided by admission BG level: group 1 (< 7.8 mmol/L), group 2 (7.8–10.9 mmol/L), group 3 (11.0–16.5 mmol/L), and group 4 (≥ 16.6 mmol/L). RESULTS: A total of 105 patients died in CICU (62 non-diabetic patients [5.2%] and 43 diabetic patients [7.9%]; P = 0.105). The CICU mortality rate increased with admission BG level (1.7%, 4.8%, 10.3%, and 18.8% from group 1 to group 4, respectively; P < 0.001). On multivariable analysis, hypertension, mechanical ventilator, continuous renal replacement therapy, acute physiology and chronic health evaluation II (APACHE II) score, and admission BG level significantly influenced CICU mortality in non-diabetic patients (group 1 vs. group 3: hazard ratio [HR], 3.31; 95% confidence interval [CI], 1.47–7.44; P = 0.004; group 1 vs. group 4: HR, 6.56; 95% CI, 2.76–15.58; P < 0.001). However, in diabetic patients, continuous renal replacement therapy and APACHE II score influenced CICU mortality but not admission BG level. CONCLUSION: Admission BG level was associated with increased CICU mortality in critically ill, non-diabetic patients admitted to CICU but not in diabetic patients.
APACHE
;
Blood Glucose
;
Cardiovascular Diseases
;
Critical Care
;
Critical Illness
;
Diabetes Mellitus
;
Humans
;
Hypertension
;
Intensive Care Units
;
Mortality
;
Prognosis
;
Renal Replacement Therapy
;
Ventilators, Mechanical
10.Clinical application of the Pediatric Acute Lung Injury Consensus Conference definition of acute respiratory distress syndrome.
Byuh Ree KIM ; Soo Yeon KIM ; In Suk SOL ; Yoon Hee KIM ; Kyung Won KIM ; Myung Hyun SOHN ; Kyu Earn KIM
Allergy, Asthma & Respiratory Disease 2019;7(1):44-50
PURPOSE: Despite improved quality of intensive care, acute respiratory distress syndrome (ARDS) significantly contributes to mortality in critically ill children. As pre-existing definitions of ARDS were adult-oriented standards, the Pediatric Acute Lung Injury Consensus Conference (PALICC) group released a new definition of pediatric ARDS. In this study, we aimed to assess the performance of PALICC definition for ARDS risk stratification. METHODS: Total 332 patients who admitted to the intensive care unit at Severance Hospital from January 2009 to December 2016 and diagnosed as having ARDS by either the PALICC definition or the Berlin definition were retrospectively analyzed. Patient characteristics and mortality rates were compared between the individual severity groups according to both definitions. RESULTS: The overall mortality rate was 36.1%. The mortality rate increased across the severity classes according to both definitions (26% in mild, 37% in moderate and 68% in severe by the PALICC definition [P<0.001]; 20% in mild, 32% in moderate and 64% in severe by the Berlin definition [P<0.001]). The mortality risk increased only for severe ARDS in both definitions (hazard ratio [95% confidence interval]: 2.279 [1.414–3.672], P=0.001 by the PALICC definition; 2.674 [1.518–4.712], P=0.001 by the Berlin definition). There was no significant difference in mortality discrimination between the 2 definitions (difference in integrated area under the curve: 0.017 [−0.018 to 0.049]). CONCLUSION: The PALICC definition demonstrated similar discrimination power on PARDS' severity and mortality as the Berlin definition.
Acute Lung Injury*
;
Berlin
;
Child
;
Consensus*
;
Critical Care
;
Critical Illness
;
Discrimination (Psychology)
;
Humans
;
Intensive Care Units
;
Mortality
;
Respiratory Distress Syndrome, Adult*
;
Retrospective Studies

Result Analysis
Print
Save
E-mail